LMRI (Lumexa Imaging Holdings) ROCE %: 4.87% (As of Mar. 2026)


LMRI Lumexa Imaging Holdings Inc LMRI
8 GF Score
Price $12.10
! 2 Warning Signs
View Full Analysis

What is Lumexa Imaging Holdings ROCE %?

Lumexa Imaging Holdings LMRI +14.37% 8 ROCE % is 4.87% as of Mar. 2026. GuruFocus rates LMRI with a GF Score™ of 8/100. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Lumexa Imaging Holdings's annualized ROCE % for the quarter that ended in Mar. 2026 was 4.87%.

Lumexa Imaging Holdings  (NAS:LMRI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Lumexa Imaging Holdings ROCE % Related Terms

Lumexa Imaging Holdings ROCE % Historical Data

* Premium members only.

The historical data trend for Lumexa Imaging Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lumexa Imaging Holdings ROCE % Chart

Lumexa Imaging Holdings Annual Data
Trend Dec23 Dec24 Dec25
ROCE %
1.49 3.78 5.60

Lumexa Imaging Holdings Quarterly Data
Dec23 Dec24 Mar25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial 4.09 6.83 0.00 0.71 4.87
LMRI
8GF Score
Lumexa Imaging Holdings Inc LMRI
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lumexa Imaging Holdings ROCE % Calculation

Lumexa Imaging Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=86.32/( ( (1670.564 - 173.66) + (1764.557 - 179.194) )/ 2 )
=86.32/( (1496.904+1585.363)/ 2 )
=86.32/1541.1335
=5.60 %

Lumexa Imaging Holdings's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=77.648/( ( (1764.557 - 179.194) + (1763.353 - 157.933) )/ 2 )
=77.648/( ( 1585.363 + 1605.42 )/ 2 )
=77.648/1595.3915
=4.87 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 4.87% mean?
Lumexa Imaging Holdings (LMRI) has a ROCE % of 4.87% as of Mar. 2026.
Is Lumexa Imaging Holdings' ROCE % too high?
Lumexa Imaging Holdings' current ROCE % is 4.87%. The Medical Devices & Instruments industry median ROCE % is 2.23. Lumexa Imaging Holdings' value of 4.87% is 118.4% above this industry median. Overall, Lumexa Imaging Holdings has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Lumexa Imaging Holdings' ROCE % compare to SSII and CBLL?
Lumexa Imaging Holdings' ROCE % of 4.87% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Lumexa Imaging Holdings' value of 4.87% is 118.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lumexa Imaging Holdings's current ROCE % of 4.87% is 118.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lumexa Imaging Holdings's current ROCE % is 4.87%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumexa Imaging Holdings stock overvalued right now?
Lumexa Imaging Holdings (LMRI) has a current ROCE % of 4.87%. The current ROCE % is 4.87% and 118.4% above the Medical Devices & Instruments industry median of 2.23. Lumexa Imaging Holdings' overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Lumexa Imaging Holdings (LMRI), the current ROCE % is 4.87% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lumexa Imaging Holdings Business Description

Address 4200 Six Forks Road, Suite 1000, Raleigh, NC, USA, 27609
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
8GF Score

Get the complete analysis for LMRI

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.10
Price